New research suggests that the HPV vaccine prevents cancer in each men and girls. However, fewer boys than girls within the United States receive the vaccine.
The HPV vaccine was developed to stop cervical cancer in women. Experts attribute it, along with screening tests, Reducing the speed of cervical cancer. Evidence that the vaccines prevent HPV-related cancers in men has been slow to emerge, but latest research suggests that vaccinated men have fewer cancers. Mouth and throat in comparison with those that didn’t receive the vaccine. These cancers are greater than twice as common in men as in women.
For the study, researchers compared 3.4 million people of comparable age – half vaccinated, half unvaccinated – using a big health dataset.
As expected, vaccinated women had a lower risk of developing cervical cancer inside not less than five years of vaccination. There were advantages for men too. Vaccinated men had a lower risk of developing HPV-related cancers corresponding to cancer of the anus, penis, and mouth and throat.
These cancers take years to develop, so the numbers were low: amongst unvaccinated men, there have been 57 HPV-related cancers – mostly head and neck cancer – compared with 26 amongst men who had received the HPV vaccine.
“We believe the greatest benefit of the vaccine will occur in the next two or three decades,” said study co-author Dr. Joseph Curry, a head and neck surgeon on the Sidney Kimmel Cancer Center in Philadelphia. “What we’re showing here is an early wave of effectiveness.”
The results of this and a second study were released Thursday by the American Society of Clinical Oncology and might be discussed at its annual meeting in Chicago next month. The second study shows that while vaccination rates are increasing, men are lagging behind women in HPV vaccination.
HPV, or human papillomavirus, could be very common and is transmitted through sex. Most HPV infections cause no symptoms and go away without treatment. Others grow to be cancer, about 37,000 cases annually, based on the Centers for Disease Control and Prevention.
In the United States, HPV vaccination has been really useful for women aged 11 or 12 since 2006 and for boys of the identical age since 2011. Booster vaccinations are really useful for all individuals as much as the age of 26 who haven’t yet been vaccinated.
In the second study, researchers examined parent- and self-reported HPV vaccination rates amongst adolescents and young adults in a big government survey. From 2011 to 2020, vaccination rates increased from 38% to 49% amongst girls and from 8% to 36% amongst boys.
“The number of young men getting vaccinated against HPV has more than quadrupled in the last decade, although vaccination rates among young men still lag behind those of women,” said study co-author Dr. Danh Nguyen of the University of Texas Southwestern Medical Center in Dallas.
Parents of each girls and boys should know that HPV vaccinations reduce the chance of cancer, said Jasmin Tiro of the University of Chicago Medicine Comprehensive Cancer Center, who was not involved within the study. And young men who haven’t been vaccinated can still get the vaccine.
“It’s really important that teenagers get the vaccine before they are exposed to the virus,” she said.
